| Abstract: | This report discusses US drug delivery systems demand for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and application segmentation, technological and product development, pharmaceutical industry overview and trade, market environment, product and application forecasts, industry composition and leading participants. Product segments include oral, parenteral, inhalation, and transdermal and implantable drug delivery systems; application segments cover central nervous system agents, respiratory agents, hormones and related agents, gastrointestinal agents, and other agents. This 21 page report also includes a highlights summary and a resources section.
|
| Brief Excerpt: | ...Demand for drug delivery systems in t he US is forecast to grow 7.3 percent per year between 2005 and 2010 to $105.6 billion, driven by technological advancements that will provide pati ents with products that deliver drugs more effectively, easily, accurately, safely and conveniently. are of controlled-release products such as sleep aids and pain relievers. c ch as prefilled syringe s; and needle-free injection delivery with demand totaling $18.0 billion in 2010, spurred by growth of st gains ent per year from 2005, a result of the high number of anticancer drugs in development that will reach the ivery system In 2005, the largest producers of drug delivery systems for the US market were Johnson & Johnson, Cardinal Heal th and Baxter International. Oral drug delivery systems are expected to generate the largest sh demand in 2010, 43 percent, boosted by an expanding number of Parenteral drug delivery syst ems are projected to o ffer the fastest...
|
| Industry: | Life Sciences (Pharmaceuticals/Medical)
|
| SIC: | 2833, 2834, 2835, 2836, 3842
|
| NAICS: | 325411, 325412, 325413, 325414, 339113
|
| Company(ies): | 3M Company, Abbott Laboratories Incorporated, Amgen Incorporated, AstraZeneca PLC, Becton, Dickinson and Company, Catalent Pharma Solutions Incorporated, Elan Corporation plc, Eli Lilly and Company, Genentech Incorporated, GlaxoSmithKline plc, Johnson & Johnson, Merck & Company Incorporated, Novartis International AG, Pfizer Incorporated, Sanofi-Aventis SA, Wyeth
|
| Ticker(s): | ABT, AMGN, AZN, BDX, DNA, ELN, GSK, JNJ, LLY, MMM, MRK, NVS, PFE, SNY, WYE
|
| Country(ies): | United States, US
|
| Free Sample: |
Click Here to Download
|
| Format: | | PDF |  |
|
